Abstract:Abstract Objectives Red raspberry (RR) polyphenols, including ellagic acid and their gut-derived metabolites, the urolithins, reduce inflammation and improve insulin sensitivity. However, it is unknown whether the gut microbiota is responsible for these health benefits and why certain individuals do not transform ellagic acid into urolithins. Here, we determined the causative role for the microbiome in mediating the health benefits from RR polyphenols using germ-free and conventionalized mouse models of diet-induced obesity. We also tested whether Gordonibacter urolithinfaciens (G. uro), a gut microbe previously shown to metabolize ellagic acid into urolithins, could enhance metabolic benefits when administered as a synbiotic with RR polyphenols. Methods RR polyphenols were extracted using a macroporous ion-exchange resin column to remove sugars and fibers. C3H/HeN mice with (CVZ) or without a microbiota (GF) were fed either a low fat (LF), high fat (HF), or HF diet with RR polyphenols (HF + RR) for 12 weeks. For synbiotic studies, GF C57BL/6 mice were given a G. uro deficient-microbiome and then fed either a HF or HF + RR diet plus 20% fructose water with or without G. uro for 7 weeks. Results Feeding a HF diet increased body weight and fat mass for both GF and CVZ mice compared to feeding a LF diet (P < 0.05). Feeding a HF diet with RR polyphenols significantly decreased visceral adipose tissue and liver triglycerides (P < 0.05) compared to a HF control diet in CVZ but not GF mice. G. uro administration to mice receiving a HF diet and fructose water significantly reduced body weight, body fat percentage, fasting blood glucose, and subcutaneous adipose tissue mass as well as increased ileal tight junction protein gene expression (P < 0.05) compared to controls. Notably, mice supplemented with both G. uro and RR polyphenols experienced no metabolic improvements compared to controls (P < 0.05). Conclusions Our results demonstrate that the microbiome is required for mediating RR polyphenol metabolic benefits. Supplementation of G. uro improved metabolic health; however, those beneficial effects were abrogated in the presence of RR polyphenols. Together, these results highlight the importance of considering specific diet-microbiota interactions when developing foods for preventing and treating obesity-related diseases. Funding Sources USDA NIFA.

The Utilization of Urolithin A—A Natural Polyphenol Metabolite of Ellagitannins As a Modulator of the Gut Microbiota for Its Potential Use in Obesity Therapy

Effects of Urolithins on Obesity-Associated Gut Dysbiosis in Rats Fed on a High-Fat Diet.

6-Gingerol, an Active Ingredient of Ginger, Reshapes Gut Microbiota and Serum Metabolites in HFD-induced Obese Mice

Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet

Modulation of the Gut Microbiota During High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet

Comparative Analysis of the Impact of Urolithins on the Composition of the Gut Microbiota in Normal-Diet Fed Rats

Urolithin B Protects Mice from Diet-Induced Obesity, Insulin Resistance, and Intestinal Inflammation by Regulating Gut Microbiota Composition.

Ursolic acid ameliorates obesity of mice fed with high-fat diet via alteration of gut microbiota and amino acid metabolism

Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice

Gut microbial metabolite urolithin B protects from insulin resistance and intestinal inflammation in association reshaping gut microbiota of obseity mice

The Gut Microbiota Regulates the Metabolic Benefits Mediated by Red Raspberry Polyphenols

Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases

Therapeutic efficacy of gut microbiota-derived polyphenol metabolite Urolithin A

Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice

Therapeutic Potential of Inulin‐Coated MCT Microcapsules in Modulating the Gut Microbiome for Effective Treatment of Diet‐Induced Obesity

In Vivo and In Silico Investigation of the Anti-Obesity Effects of Lactiplantibacillus plantarum Combined with Chia Seeds, Green Tea, and Chitosan in Alleviating Hyperlipidemia and Inflammation

Urolithin A Attenuates Diabetes-Associated Cognitive Impairment by Ameliorating Intestinal Barrier Dysfunction via N-glycan Biosynthesis Pathway

Arabinoxylan Alleviates Obesity by Regulating Gut Microbiota and Bile Acid Metabolism

Inhibition of the NF-κB and mTOR targets by urolithin A attenuates D-galactose-induced aging in mice

Lactobacillus acidophilus JYLA-126 Ameliorates Obesity-Associated Metabolic Disorders by Positively Regulating the AMPK Signaling Pathway Through the Gut-Liver Axis

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling